COVID-19 Vaccines & Boosters at Chapa-De
Click HERE to schedule a vaccine appointment
Or walk-in, no appointment necessary Monday thru Friday 8:30 AM – 11:00 AM and 1:30 PM – 4:00 PM (excluding holidays)
We offer both the Moderna and Pfizer mRNA vaccines and the single dose Johnson & Johnson vaccine
1st & 2nd doses are available to established Chapa-De patients age 12 and over
3rd doses and booster shots are also available to certain groups age 18 and over – please see details below
COVID-19 vaccines are free to patients
There are many local choices for getting your COVID-19 vaccine and booster. Please visit your local pharmacy, see myturn.ca.gov, or call 2-1-1 to find additional options that may work for you.
All Chapa-De Patients age 12 and over are now eligible for a COVID-19 Vaccine at Chapa-De
This page will be updated regularly with the most current information about boosters and as vaccines are approved and available for younger children. Please bookmark this page so that you can easily refer to it.
Chapa-De Staff, American Indian Elders, Chapa-De Patients Age 12+, 3rd Doses for Immunocompromised Patients and Pfizer Booster Shots for Eligible Groups
American Indians 65 Years of Age or Older
Established Chapa-De Patients 12 Years of Age or Older
Not Yet Eligible:
Children Under Age 12 and Booster Shots for Most Patients
Ready to protect yourself and loved ones from COVID-19?
If you are within an eligible group above and you can answer "NO" to all the questions below, please visit a Chapa-De Medical Department between these hours for a free COVID-19 vaccine: Monday thru Friday 8:30 AM – 11:00 AM and 1:30 PM – 4:00 PM (excluding holidays)
In the last two weeks have you:
1. Had a fever, cough, shortness of breath, difficulty breathing, sore throat, nasal congestion, runny nose, muscle or body aches, headache, fatigue, nausea, vomiting, diarrhea, chills, or new loss of taste/smell?
2. Tested positive or been in contact with someone testing positive for COVID-19 in last 14 days.
3. In the last 90 days, have you received monoclonal antibody treatment for COVID-19?